Jurgen Kuball
@JKuball
https://www.linkedin.com/pub/jurgen-kuball/88/156/49b http://www.umcutrecht.nl/nl/Ziekenhuis/Zorgverleners/Kuball
It’s always about creating and using better alternatives ….. now also on ….. bsky.app/profile/jkubal…
Help spread the word! 😊📢 @CChabannon @ARampotas @drjgauthier @gulderenesra @YasSerroukh @Satyayadav__ @Mohty_EBMT @i_yakoub_agha @HematoRules @zina_peric @RadiciVera @Claire_P_Horgan @krzysztofkalwak @larsgjaerde @BldCancerDoc @AkshaySharmaMD @RDuarte_EBMT @JKuball…
🧵Twitter Thread:🧵 EBMT 2025 Abstract Submission & Opportunities! 1/ 🚨 Reminder for Physicians, Data Managers, Statisticians, Psychologists, Pharmacists & Patient Advocates! You have 1 week left to submit your abstracts for #EBMT25. 🗓 Deadline: This Sunday! Submit here 👉…
Excellent presentation of @CChabannon on tisagenlecleucel for the Management of Patients with R/R DLBCL: an Interim Report of the European PASS Conducted by EBMT @TheEBMT_CTIWP @AnnalisaRugger1
Work supported by @TheEBMT_CTIWP @AnnalisaRugger1 @Florent_Malard
CONGRESS #ASH24 | POSTER @Jkuball, @UMCUtrecht, presented a poster on MSCs in SR-aGvHD. ORR at day 7 was 26.5% and 44.5% at day 28. At 12 mo, NRM was 58.8%. 84.8% of day 7 responders maintained response to day 28. Follow our live feed for more updates: gvhdhub.com/medical-inform……
CONGRESS #ASH24 | POSTER @Jkuball, @UMCUtrecht, presented a poster on MSCs in SR-aGvHD. ORR at day 7 was 26.5% and 44.5% at day 28. At 12 mo, NRM was 58.8%. 84.8% of day 7 responders maintained response to day 28. Follow our live feed for more updates: gvhdhub.com/medical-inform……
The @GoCARTcoalition is an inclusive initiative bringing together many stakeholders interested in the development of IECs based therapies. Results of the first supported scientific projects now coming out. Congratulations
Excellent presentation by Dr. Giorgio Ottaviano on the RWE of alloHCT after CART19 in B-ALL: a study on behalf of the GoCART coalition.🙌 #ASH24 @GiorgiOttaviano @GoCARTcoalition @EHA_Hematology @TheEBMT
🔎 Have you seen this publication in @BMTjournal? 📰 Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working…
Do you know how to design innovative CAR T cells? The TCR is an incredible inspiration and has tons to teach us! Check our latest perspective in Nat Rev Immunology: rdcu.be/dXDkG You will find a new exciting way to look at CAR T cells! @CIBSS_UniFR @BUnifr @UniFreiburg
Excellent review from the lab about CAR design 😍 Look inside 👀
Do you know how to design innovative CAR T cells? The TCR is an incredible inspiration and has tons to teach us! Check our latest perspective in Nat Rev Immunology: rdcu.be/dXDkG You will find a new exciting way to look at CAR T cells! @CIBSS_UniFR @BUnifr @UniFreiburg
Amazing session at @_CTGCT_ with Jane Kinghorn UCL and Heiko van der Leyen in Ljubljana on how to make translational medicine in ATMP development more efficient and attractive to a next generation of researchers, regulators and investors.
The 1st Joint Educational Meeting of the Autoimmune Diseases & @TheEBMT_CTIWP Working Parties in Milan was a success! 👏 The event brought together top experts and a broad international audience to discuss advances in cellular therapies, particularly CAR-T, in relation to…
Joined meeting in Milano CART in auto immune diseases and finally a joined picture of our amazing team 😀 @AnnalisaRugger1 @JKuball @Florent_Malard @pagliuca_simona
⏺️ Live from 📍 Milan: We have just opened the joint meeting of Immunology and Cellular Therapies in Autoimmune Diseases! 💡 During the next few days, this event hosted by the Autoimmune Diseases Working Party (ADWP) and the Cellular Therapy and Immunobiology Working Party…
Excellent time in Utrecht giving seminar and talking science with @JKuball and @ZsoltSebestyen2 and colleagues :)
After Movie ….. official opening of ICAT youtu.be/3kKCSJ4PuLc?fe… @cancercenterumc @CTI_UMCUtrecht @ZsoltSebestyen
Last days of a survey of @GoCARTcoalition @t2evolve_imi @TheEBMT_CTIWP on the needs for ATMP development. Which system or sensors we need, viral or non viral? One participant per hospital / company needed. surveymonkey.com/r/ATMPfaciliti…
Finally out kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2… The genesis of @TheEBMT #CART Cells registry @JKuball @Mohty_EBMT @AnnaSureda5 @AnnalisaRugger1
9000 it was and let’s go for the 10.000: Celebrating the registration of 9.000 patients treated with CAR T cell... sciencedirect.com/science/articl… @CChabannon @TheEBMT_CTIWP @AnnalisaRugger1 @AnnaSureda5 @TheEBMT @GoCARTcoalition
One day after world blood cancer day: stamina and world wide networks to advance are field are rewarded: Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort sciencedirect.com/science/articl…